| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.08 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.24 | 0.08 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |